SD

Silpa Devnath

Active Director Additional Director DIN 11383531
DIN 11383531 First appointment Nov 2025 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Silpa Devnath

Data last updated:

Silpa Devnath is an Additional Director at Mcnathe Pharmaceuticals Private Limited (since 2025). The company operates in Chemicals.

DIN 11383531
Primary Designation Additional Director
Industry Chemicals
First Appointment 14 Nov 2025
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director14 Nov 20252020Active

Board colleagues of Silpa Devnath

NameDINCompanyDesignation
Nabin Nath08814210Mcnathe Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mcnathe Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Silpa Devnath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Silpa Devnath

Silpa Devnath currently holds 1 directorship: Mcnathe Pharmaceuticals Private Limited (Additional Director, since 14 Nov 2025).

Silpa Devnath was first appointed on 14 Nov 2025 as Additional Director at Mcnathe Pharmaceuticals Private Limited.

The current boards of Silpa Devnath's companies include Nabin Nath (Mcnathe Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available